| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 01/09/2003 | US20030009023 Isolation and method of using tissue growth-inducing Frzb protein |
| 01/09/2003 | US20030008840 Methods for treating cancer |
| 01/09/2003 | US20030008836 Eukaryotic gene expression cassette and uses thereof |
| 01/09/2003 | US20030008810 Nutritional intervention composition for enhancing and extending satiety |
| 01/09/2003 | US20030008399 Controlling viral replication or gene expression in a cell; obtain cell infected with virus, transform with nucleotide sequence expressng preferential replicases, monitor viral gene expression |
| 01/09/2003 | US20030008394 Method for culturing langerhans islets and islet autotransplantation islet regeneration |
| 01/09/2003 | US20030008393 Cell culture for use as tools in treatment of cancer and metabolic diseases |
| 01/09/2003 | US20030008391 Methods and compositions for modulating the interaction between the APJ receptor and the HIV virus |
| 01/09/2003 | US20030008390 Genetically engineered cell for use in the generation of viral vector for use in gene therapy |
| 01/09/2003 | US20030008376 Methods and compositions for modulating the interaction between the APJ receptor and the HIV virus |
| 01/09/2003 | US20030008375 Generation of preferential adenoviral expression vector; obtain cells, infect with virus, harvest and lyse cell, recover vectors |
| 01/09/2003 | US20030008349 Molecular regulatory circuits to achieve sustained activation of genes of interest by a single stress |
| 01/09/2003 | US20030008300 Amplification of nitroso compouds in erythrocytes; obtain mammal, inject with therapeutic agent, monitor concentration levels of preferential nitroso compounds |
| 01/09/2003 | US20030008279 Cells for use in the diagnosis and treatment of viral diseases |
| 01/09/2003 | US20030008274 Nucleotide sequences coding polypeptide for use in the treatment of and prevention of viral diseases |
| 01/09/2003 | US20030008273 Methods for increasing the survival of neuronal cells |
| 01/09/2003 | US20030008023 Methods for inhibiting cancer growth, reducing infection and promoting general health with a fermented soy extract |
| 01/09/2003 | US20030008016 Prophylactic and therapeutic nutritional supplement for creation/maintenance of health-protective intestinal microflora and enhancement of the immune system |
| 01/09/2003 | US20030007977 Vaccine containing amino acid |
| 01/09/2003 | US20030007968 Administering bone marrow cells with lymphyocytes removed; then busulfan |
| 01/09/2003 | US20030007967 Nitrosylation of protein SH groups and amino acid residues as a therapeutic modality |
| 01/09/2003 | US20030007963 Treatment of pompe's disease |
| 01/09/2003 | US20030007957 Novel wound healing composition not containing bovine-derived activating reagents |
| 01/09/2003 | US20030007955 Enclosures housing cell-coated supports for treating tumors |
| 01/09/2003 | US20030007954 Cardiovascular disorder; strokes; gene therapy |
| 01/09/2003 | US20030007953 Animal food; prevention acidosis |
| 01/09/2003 | US20030007952 Polypeptides |
| 01/09/2003 | US20030007938 Methods for treating fingernails and toenails |
| 01/09/2003 | CA2446580A1 Process and apparatus for utilization of in vivo extracted plasma with tissue engineering devices, bioreactors, artificial organs, and cell therapy applications |
| 01/08/2003 | EP1272652A2 Herpes viruses for immune modulation |
| 01/08/2003 | EP1272636A2 A gene differentially expressed in breast and bladder cancer and encoded polypeptides |
| 01/08/2003 | EP1272633A2 Compositions and methods for dendritic cell-based immunotherapy |
| 01/08/2003 | EP1272619A2 Human ovarian mesothelial cells and methods of isolation and uses thereof |
| 01/08/2003 | EP1272618A2 Synchronization of the cytoplasmatic and nuclear maturation of oocytes in vitro |
| 01/08/2003 | EP1272616A2 Human pancreatic epithelial progenitor cells and methods of isolation and use thereof |
| 01/08/2003 | EP1272615A2 Osteocalcin promoter directed adenovirus replicaton for therapy |
| 01/08/2003 | EP1272614A1 Differentiation of bone marrow cells into neuronal cells and uses therefor |
| 01/08/2003 | EP1272518A2 Cd20/ige-receptor like molecules and uses thereof |
| 01/08/2003 | EP1272506A1 Human aminoacyl-trna synthetase polypeptides useful for the regulation of angiogenesis |
| 01/08/2003 | EP1272236A1 Methods and compositions for treating intervertebral disc degeneration |
| 01/08/2003 | EP1272206A1 Non-mammalian gnrh analogs and uses thereof in tumor cell growth regulation and cancer therapy |
| 01/08/2003 | EP1272204A2 Soft tissue and bone augmentation and bulking utilizing muscle-derived progenitor cells, compositions and treatments thereof |
| 01/08/2003 | EP1272203A2 Treatment of disorders by implanting stem cells and/or progeny thereof into gastrointestinal organs |
| 01/08/2003 | EP1272044A1 Protein stabilised emulsions |
| 01/08/2003 | EP0859622B1 Extracts of shark cartilage |
| 01/08/2003 | EP0833649B1 Methods of preventing or treating allergies |
| 01/08/2003 | EP0796107B1 Sunscreen-wound healing composition |
| 01/08/2003 | EP0728194B1 In situ modification and manipulation of stem cells of the central nervous system |
| 01/08/2003 | EP0607309B1 The regulation of systemic immune responses utilizing cytokines and antigens |
| 01/08/2003 | CN1390257A Transfer compounds, the production and the use thereof |
| 01/08/2003 | CN1390218A New active marine alkaloids |
| 01/08/2003 | CN1390141A Nucleic acid-containing complex |
| 01/08/2003 | CN1390130A Glucosamine and egg for reducing inflammation |
| 01/08/2003 | CN1390120A Compression molded product and production method therefor |
| 01/08/2003 | CN1389261A Externally applied Chinese medicine for treating trauma and its prepn. |
| 01/08/2003 | CN1389259A Psoriasis-treating ointment and its compounding process |
| 01/08/2003 | CN1389253A Composite medicine for treating cancer of esophagus |
| 01/08/2003 | CN1389252A Composite medicine for treating femoral head necrosis |
| 01/08/2003 | CN1389239A Complete granule for treating hepatocirrhosis and liver ascites and its prepn. |
| 01/08/2003 | CN1389234A Lithiasis treating medicine |
| 01/08/2003 | CN1389233A Medicine for treating gastroduodenal ulcer |
| 01/08/2003 | CN1389229A Intestine and stomach conditioning oral liquor |
| 01/08/2003 | CN1389218A Combined supercritical and auxiliary microwave extraction process of separating effective bee glue components |
| 01/08/2003 | CN1389217A Wind and cold dispelling Chinese medicine for treating Bell's palsy and its prepn. |
| 01/08/2003 | CN1389216A Effective component extract of Manta birostris and its prepn. and application |
| 01/08/2003 | CN1098102C Medicine for treating rheumatism and its preparing process |
| 01/08/2003 | CN1098097C External-use ointment for treating burns and scalds |
| 01/08/2003 | CN1098093C Medicine for treating aphtha and its preparation method |
| 01/08/2003 | CN1098092C Capsule for treating rhematism |
| 01/08/2003 | CN1098087C Chinese medicine for treating cancers and its preparing process |
| 01/08/2003 | CN1098086C Mastic for treating acne |
| 01/08/2003 | CN1098084C Marine active substance and composition comprising the same |
| 01/08/2003 | CN1098083C Artificial tiger-bone and its producing process and use |
| 01/08/2003 | CN1098075C Broad-spectrum antibacterial medicine and its exterior application method |
| 01/07/2003 | US6504012 Polyethylene glycol fractionation of impure gamma-globulin, treating with an organic solvent for inactivated envelope viruses, and heat treating to inactivate heat sensitive viruses, removing aggregates generated from heat treatment |
| 01/07/2003 | US6504011 Recombinantly produced serum albumin is purified in a series of steps, optionally by incubation with an anion-exchange adsorbent, followed by affinity chromatography employing a hydrophobic solid phase and using a water-soluble lipid anion |
| 01/07/2003 | US6503888 AAV-mediated delivery of DNA to cells of the nervous system |
| 01/07/2003 | US6503887 Peroral gene therapy of diabetes and obesity |
| 01/07/2003 | US6503882 Treatment of HIV |
| 01/07/2003 | US6503731 Fibrin microbeads prepared from fibrinogen, thrombin and factor XIII for binding cells |
| 01/07/2003 | US6503699 Method for photodecontamination of pathogens in blood using 5'-primary aminopsoralens |
| 01/07/2003 | US6503539 Matrix protein compositions for wound healing |
| 01/07/2003 | US6503530 Method of preventing development of severe metabolic derangement in inborn errors of metabolism |
| 01/07/2003 | US6503512 Anti-AIDS immunomodulator complex |
| 01/07/2003 | US6503505 Plant extract veterinary feed additive; food additive for enhancing weight gain in a recipient; Escherichia coli strain BU-230-98 ATCC Deposit No. 20226 (DSM 12799). |
| 01/07/2003 | US6503501 Targetable vector particles |
| 01/07/2003 | US6503499 Viral particle comprising gene of interest operably linked to a promoter and envelope protein affixed with bifunctional adapter and a biotin molecule; internalizing into target cell for transduction and gene expression |
| 01/07/2003 | US6503273 Tissue engineered blood vessels and methods and apparatus for their manufacture |
| 01/07/2003 | CA2137797C System for treating transition zone material |
| 01/03/2003 | WO2003001198A1 Immortalization of human cells by the ectopic expression of human telomerase reverse transcriptase |
| 01/03/2003 | WO2003000896A2 POLYNUCLEOTIDES AND POLYPEPTIDES OF THE IFNα-5 GENE |
| 01/03/2003 | WO2003000889A2 Identification of ses-1 and the uses of the same |
| 01/03/2003 | WO2003000871A1 Schwann cells originating in myeloid interstitial cells |
| 01/03/2003 | WO2003000870A1 Culture method for cartilage differentiation |
| 01/03/2003 | WO2003000868A1 Dopaminergic neurons and proliferation-competent precursor cells for treating parkinson's disease |
| 01/03/2003 | WO2003000852A2 Method of producing region-specific neurons from human neuronal stem cells |
| 01/03/2003 | WO2003000851A2 Method for rapid screening of bacterial transformants and novel simian adenovirus proteins |
| 01/03/2003 | WO2003000848A2 Liver engrafting cells, assays, and uses thereof |
| 01/03/2003 | WO2003000720A1 Novel human cytomegalovirus (hcmv) cytotoxic t cell epitopes, polyepitopes, compositions comprising same and diagnostic and prophylactic and therapeutic uses therefor |
| 01/03/2003 | WO2003000283A1 Methods of inducing a cytotoxic immune response and recombinant simian adenovirus compositions useful therein |